Flexibility to build studies in-house

Ray Carlburg, Associate Director of Data Management at Poseida Therapeutics, shares how the flexibility of the Zelta platform empowered his team to build studies in-house -- giving them greater control over resourcing and trial timelines, eliminating communication challenges, and saving significant time and money that would otherwise be spent on expensive, time-consuming vendors.
Learn more at www.merative.c....
Connect with us on LinkedIn ➔ / zelta-by-merative